By
Intas Pharma may reconsider proposed IPO, could look at PE deal to give ChrysCap part exit

Intas Pharmaceuticals Ltd, which had filed its draft red-herring prospectus (DRHP) with SEBI for a proposed initial public offering (IPO) three months ago to give part exit to existing investor ...

TO READ THE FULL STORY


Leave Your Comment(s)